TRPA1 involvement in depression- and anxiety-like behaviors in a progressive multiple sclerosis model in mice
- PMID: 34280479
- DOI: 10.1016/j.brainresbull.2021.07.011
TRPA1 involvement in depression- and anxiety-like behaviors in a progressive multiple sclerosis model in mice
Abstract
Progressive multiple sclerosis (PMS) is a neurological disease associated with the development of depression and anxiety, but treatments available are unsatisfactory. The transient receptor potential ankyrin 1 (TRPA1) is a cationic channel activated by reactive compounds, and the blockage of this receptor can reduce depression- and anxiety-like behaviors in naive mice. Thus, we investigated the role of TRPA1 in depression- and anxiety-like behaviors in a PMS model in mice. PMS model was induced in C57BL/6 female mice by the experimental autoimmune encephalomyelitis (EAE). Nine days after the PMS-EAE induction, behavioral tests (tail suspension and elevated plus maze tests) were performed to verify the effects of sertraline (positive control), selective TRPA1 antagonist (A-967,079), and antioxidants (α-lipoic acid and apocynin). The prefrontal cortex and hippocampus were collected to evaluate biochemical and inflammatory markers. PMS-EAE induction did not cause locomotor changes but triggered depression- and anxiety-like behaviors, which were reversed by sertraline, A-967,079, α-lipoic acid, or apocynin treatments. The neuroinflammatory markers (AIF1, GFAP, IL-1β, IL-17, and TNF-α) were increased in mice's hippocampus. Moreover, this model did not alter TRPA1 RNA expression levels in the hippocampus but decrease TRPA1 levels in the prefrontal cortex. Moreover, PMS-EAE induced an increase in NADPH oxidase and superoxide dismutase activities and TRPA1 endogenous agonist levels (hydrogen peroxide and 4-hydroxynonenal). TRPA1 plays a fundamental role in depression- and anxiety-like behaviors in a PMS-EAE model; thus, it could be a possible pharmacological target for treating these symptoms in PMS.
Keywords: Antioxidants; Experimental autoimmune encephalomyelitis; Hippocampus; NADPH oxidase; Sertraline; Superoxide dismutase.
Copyright © 2021 Elsevier Inc. All rights reserved.
Similar articles
-
Nociception in a Progressive Multiple Sclerosis Model in Mice Is Dependent on Spinal TRPA1 Channel Activation.Mol Neurobiol. 2020 May;57(5):2420-2435. doi: 10.1007/s12035-020-01891-9. Epub 2020 Feb 24. Mol Neurobiol. 2020. PMID: 32095993
-
TRPA1 activation mediates nociception behaviors in a mouse model of relapsing-remitting experimental autoimmune encephalomyelitis.Exp Neurol. 2020 Jun;328:113241. doi: 10.1016/j.expneurol.2020.113241. Epub 2020 Feb 8. Exp Neurol. 2020. PMID: 32045597
-
Transient receptor potential ankyrin 1 mediates headache-related cephalic allodynia in a mouse model of relapsing-remitting multiple sclerosis.Pain. 2022 Jul 1;163(7):1346-1355. doi: 10.1097/j.pain.0000000000002520. Epub 2021 Oct 26. Pain. 2022. PMID: 34711761
-
Increased levels of advanced oxidation protein products (AOPPs) were associated with nociceptive behavior and clinical scores in an experimental progressive autoimmune encephalomyelitis model (PMS-EAE).J Neurochem. 2024 Jun;168(6):1143-1156. doi: 10.1111/jnc.16081. Epub 2024 Feb 19. J Neurochem. 2024. PMID: 38372436
-
Experimental modeling of anxiety and depression.Acta Neurobiol Exp (Wars). 2004;64(4):439-48. doi: 10.55782/ane-2004-1526. Acta Neurobiol Exp (Wars). 2004. PMID: 15586660 Review.
Cited by
-
Proteome-wide Mendelian randomization highlights AIF1 and HLA-DQA2 as targets for primary sclerosing cholangitis.Hepatol Int. 2024 Apr;18(2):517-528. doi: 10.1007/s12072-023-10608-8. Epub 2023 Nov 11. Hepatol Int. 2024. PMID: 37950809
-
Transient receptor potential ankyrin 1 channel modulates the abuse-related mechanisms of methamphetamine through interaction with dopamine transporter.Br J Pharmacol. 2024 Aug;181(16):2794-2809. doi: 10.1111/bph.16370. Epub 2024 Apr 21. Br J Pharmacol. 2024. PMID: 38644533
-
Neuropathic Pain in Multiple Sclerosis and Its Animal Models: Focus on Mechanisms, Knowledge Gaps and Future Directions.Front Neurol. 2021 Dec 16;12:793745. doi: 10.3389/fneur.2021.793745. eCollection 2021. Front Neurol. 2021. PMID: 34975739 Free PMC article. Review.
-
Circulatory Indicators of Lipid Peroxidation, the Driver of Ferroptosis, Reflect Differences between Relapsing-Remitting and Progressive Multiple Sclerosis.Int J Mol Sci. 2024 Oct 14;25(20):11024. doi: 10.3390/ijms252011024. Int J Mol Sci. 2024. PMID: 39456806 Free PMC article.
-
Understanding the spectrum of non-motor symptoms in multiple sclerosis: insights from animal models.Neural Regen Res. 2024 Jan;19(1):84-91. doi: 10.4103/1673-5374.375307. Neural Regen Res. 2024. PMID: 37488849 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous